Aviva’s Kodiak Sciences KOD Stock Holding History

Aviva’s Portfolio KOD Stock Details KOD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-24,101	Closed	-$3.54M	–	966
2020 Q4	$3.54M	Sell	24,101 -19,536	-45%	-$2.18M	0.02%	567
2020 Q3	$2.58M	Buy	+43,637	New	+$2.19M	0.02%	588

Other funds holding KOD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aviva's KOD Position: Q1 2021 in Review

Aviva sold out of Kodiak Sciences (KOD) in Q1 2021, closing a stake of 24,101 shares — an estimated $3.54M sold.

Aviva first reported a position in KOD in Q3 2020 and held it in 2 quarters. The position peaked at $3.54M in Q4 2020. 167 funds tracked by Wall St. Rank hold KOD as of Q1 2021.

Aviva reported no remaining Kodiak Sciences position as of Q1 2021 after selling out during the quarter.
Aviva sold 24,101 Kodiak Sciences shares in Q1 2021, an estimated $3.54M.
Aviva first reported a position in Kodiak Sciences in Q3 2020 and held it in 2 quarters.
Aviva's Kodiak Sciences position peaked at $3.54M in Q4 2020.
167 funds tracked by Wall St. Rank held Kodiak Sciences as of Q1 2021.

Based on Aviva's 13F filing for Q1 2021, filed 13 May 2021.